{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:07:03Z","timestamp":1791864423483,"version":"4.3.4"},"reference-count":158,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Linear IgA bullous dermatosis (LABD) is a rare subepidermal blistering disorder characterized by the presence of linear IgA deposits at the basement membrane zone (BMZ) by direct immunofluorescence (DIF). This entity was first described by Chorzelski and Jablonska from Warsaw Center of Bullous Diseases, Poland. The disease affects children and adults, whereby they differ in terms of clinical picture and course. Among polish patients with LABD mucous membrane involvement was exceptional, although, we reported a case presenting severe scarring of esophagus and conjunctivae with circulating IgG and IgA antibodies to LAD-1 antigen. Severe mucosal involvement was also observed in IgA-epidermolysis bullosa acquisita (EBA). Immunologically, LABD is characterized by circulating IgA antibodies directed to several epitopes of antigen BP180: LAD-1, 97kD, NC16A. Other BMZ antigens, like BP230, laminin 332, type VII collagen or p200 may be affected. We as a first published a case of anti-p200kD pemphigoid mediated by IgA. Our immunoelectron microscopic studies showed that the epitopes recognized by LABD sera are ultrastructurally localized in the lamina lucida. The antigenic heterogeneity, low titer of IgA antibodies and the lack of commercially available tests for some antigens (LAD-1, p200kD) makes the diagnosis challenging in many cases. It is under debate whether these cases are the subtypes of LABD or they represent a separate entities (IgA-p200 pemphigoid, IgA-MMP or IgA-EBA). Since, they differ in terms of clinical course, mucosal involvement, coexisting disorders, response to the treatment and prognosis, their differentiation is mandatory. In the literature there are many cases with undetectable circulating IgA antibodies in whom LABD was recognized based on DIF only. To avoid misdiagnosis, more sophisticated methods should be used, like direct immunoeletron microscopy (IEM), which is a time-consuming technique. The alternative for IEM may be: a) analysis of the BMZ serration pattern, b) immunofluorescence mapping of blister, c) direct salt split (patient\u2019s) skin, d) fluorescence overlay antigen mapping by laser scanning confocal microscopy. The two latter methods were established by the authors years ago and they allowed precise diagnosis (i.e., differentiation LABD from IgA-EBA), initiation of proper therapy and assessment of prognosis in many cases mediated by IgA.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1478318","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T05:10:39Z","timestamp":1736831439000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Linear IgA bullous dermatosis\u2013a fifty year experience of Warsaw Center of bullous diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Cezary","family":"Kowalewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1976.01630250017005","article-title":"Dermatitis erpetiformis and bullous pemphigoid. Intermediate and mixed forms","volume":"112","author":"Jablonska","year":"1976","journal-title":"Arch Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12261260","article-title":"mmunofluorescence studies in the diagnosis of dermatitis herpetiformis and its differentiation from bullous pemphigoid","volume":"56","author":"Chorzelski","year":"1971","journal-title":"J Invest Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-133.1979.tb11882.x","article-title":"IgA linear dermatosis of childhood (chronic bullous disease of childhood)","volume":"101","author":"Chorzelski","year":"1979","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2133.1984.tb06601.x","article-title":"IgA antiendomysium antibody. A new immunological marker of dermatitis herpetiformis and cealic disease","volume":"111","author":"Chorzelski","year":"1984","journal-title":"Br J Dermatol"},{"key":"B5","volume-title":"Immunopathology of the skin","author":"Chorzelski","year":"1985"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/1523-747.ep12345782","article-title":"LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells","volume":"106","author":"Marinkovich","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12348993","article-title":"IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein","volume":"106","author":"Zone","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00129.x","article-title":"The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2","volume":"110","author":"Zone","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00808.x","article-title":"Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP180","volume":"113","author":"Zillikens","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.001","article-title":"Production of neoepitopes by dynamic structural changes on BP180\/type XVII collagen","volume":"137","author":"Hashimoto","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/BF00371735","article-title":"Ultrastructural localization of binding sites of sera from patients with linear IgA bullous dermatosis","volume":"287","author":"Kowalewski","year":"1995","journal-title":"Arch Dermatol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12398417","article-title":"Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patients\u2019 sera","volume":"103","author":"Haftek","year":"1994","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561449","article-title":"Electron microscopic studies in dermatitis herpetiformis in relation to the pattern of immune deposits in the skin","volume":"259","author":"Dabrowski","year":"1975","journal-title":"Arch Dermatol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12541207","article-title":"The ultrastructural localization of IgA in skin of a patient with mixed form of dermatitis herpetiformis and bullous pemphigoid","volume":"70","author":"Dabrowski","year":"1978","journal-title":"J Invest Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/BF00412386","article-title":"Immunoelectron microscopic studies in IgA linear dermatosis","volume":"265","author":"Dabrowski","year":"1979","journal-title":"Arch Dermatol Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12598569","article-title":"Dermatitis herpetiformis: immunoelectronmicroscopic and ultrastructural studies of a patient with linear deposition of IgA","volume":"67","author":"Yaoita","year":"1976","journal-title":"J Invest Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12664534","article-title":"Immunoelectronmicroscopic localisation of IgA in skin of patients with dermatitis herpetiformis","volume":"67","author":"Yaoita","year":"1976","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.303","article-title":"IgA anti-p200 pemphigoid","volume":"147","author":"Wozniak","year":"2011","journal-title":"Arch Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12720","article-title":"A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the \u03b13 subunit of laminin-332","volume":"170","author":"Zenke","year":"2014","journal-title":"Br J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1923","article-title":"A case of linear IgA\/IgG bullous dermatosis with anti-laminin-332 autoantibodies","volume":"95","author":"Izaki","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.0761","article-title":"History, diagnosis, pathogenesis, and nomenclature in sublamina densa-type linear igA disease","volume":"157","author":"Hashimoto","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.125079","article-title":"IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature","volume":"47","author":"Vodegel","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.0762","article-title":"Evaluation and comparison of clinical and iLaboratory characteristics of patients with igA epidermolysis bullosa acquisita, linear igA bullous dermatosis, and igG epidermolysis bullosa acquisita","volume":"157","author":"Becker","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"adv00070","DOI":"10.2340\/00015555-3415","article-title":"Autoantibody profile of a cohort of 54 italian patients with linear igA bullous dermatosis: LAD-1 denoted as a major auto-antigen of the lamina lucida subtype","volume":"100","author":"Cozzani","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19880","article-title":"S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology","volume":"38","author":"Caux","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13041159","article-title":"Linear igA bullous dermatosis in korea using the nationwide health insurance database","volume":"13","author":"Kim","year":"2024","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2008.00561.x","article-title":"Linear IgA dermatosis: report of an infantile case and analysis of 213 cases in Japan","volume":"35","author":"Horiguchi","year":"2008","journal-title":"J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15232","article-title":"A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence","volume":"177","author":"Ohata","year":"2017","journal-title":"Br J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1990","article-title":"Linear IgA bullous dermatosis: a retrospective study of 23 patients in Denmark","volume":"95","author":"Lings","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15244","article-title":"Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults","volume":"177","author":"Gottlieb","year":"2017","journal-title":"Br J Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1985.tb05853.x","article-title":"Linear IgA bullous dermatosis. An immunologically defined disease","volume":"24","author":"Wilson","year":"1985","journal-title":"Int J Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12017","article-title":"Fluorescence overlay antigen mapping using laser scanning confocal microscopy differentiates linear IgA bullous dermatosis from epidermolysis bullosa acquisita mediated by IgA","volume":"168","author":"Wozniak","year":"2013","journal-title":"Br J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.937528","article-title":"Linear immunoglobulin a bullous dermatosis in children","volume":"8","author":"Mori","year":"2022","journal-title":"Front Pediatr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14120","article-title":"IgA tracheobronchial deposits underlie respiratory compromise in neonatal linear IgA bullous dermatosis","volume":"31","author":"Diociaiuti","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.2392","article-title":"Neonatal linear igA bullous dermatosis mediated by breast milk-borne maternal igA","volume":"157","author":"Egami","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03110.x","article-title":"Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression","volume":"141","author":"Collier","year":"1999","journal-title":"Br J Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1980.tb01972.x","article-title":"HLA antigens in dermatitis herpetiformis among Japanese","volume":"7","author":"Hashimoto","year":"1980","journal-title":"J Dermatol"},{"key":"B38","article-title":"La dermatose bulleuse \u00e0 IgA lin\u00e9aire de l\u2019enfant. Une s\u00e9rie de 12 malades tunisiens [Iga linear bullous dermatosis in children. A series of 12 Tunisian patients","volume":"121","author":"Denguezli","year":"1994","journal-title":"Ann Dermatol Venereol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.08.011","article-title":"A celiac gene HLA-DQB1\u221702:01 is associated with linear igA bullous dermatosis in the chinese population","volume":"144","author":"Li","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2015.2668","article-title":"Mucous membrane pemphigoid with severe stricture of the esophagus mediated by IgG and IgA autoantibodies to LAD-1","volume":"25","author":"Jakubowska","year":"2015","journal-title":"Eur J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13912","article-title":"Case of linear immunoglobulin A\/immunoglobulin G bullous dermatosis showing immunoglobulin G reactivity with the 120-kDa LAD-1","volume":"44","author":"Kitoh","year":"2017","journal-title":"J Dermatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13154","article-title":"Ultraviolet-induced linear IgA bullous dermatosis: a case report and literature survey","volume":"171","author":"Wozniak","year":"2014","journal-title":"Br J Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1998.tb02444.x","article-title":"Linear IgA bullous dermatosis with circulating IgG autoantibodies to the 230 kD epidermal antigen","volume":"25","author":"Honoki","year":"1998","journal-title":"J Dermatol"},{"key":"B44","article-title":"A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen","volume":"12","author":"Watanabe","year":"2002","journal-title":"Eur J Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13921","article-title":"Linear immunoglobulin A\/immunoglobulin G bullous dermatosis with autoantibodies to LAD-1 and laminin-\u03b31","volume":"44","author":"Matsudate","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0117","article-title":"Penicillin-induced anti-p200 pemphigoid: an unusual morphology","volume":"86","author":"Wozniak","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1996.d01-1128.x","article-title":"Linear IgA dermatosis with IgA antibodies to type VII collagen","volume":"135","author":"Zambruno","year":"1996","journal-title":"Br J Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.381","article-title":"Type VII collagen is the major autoantigen for sublamina densa-type linear IgA bullous dermatosis","volume":"135","author":"Tsuchisaka","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.18191915.x","article-title":"IgA-epidermolysis bullosa acquisita in a child resulting in blindness","volume":"137","author":"Caux","year":"1997","journal-title":"Br J Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114508","article-title":"Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis","volume":"85","author":"Zone","year":"1990","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1201163","article-title":"Case Report: Prurigo nodularis-like linear IgA\/IgG bullous dermatosis: a case report and literature review","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03661.x","article-title":"IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis","volume":"143","author":"Christophoridis","year":"2000","journal-title":"Br J Dermatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13934","article-title":"Linear immunoglobulin A\/G bullous dermatosis associated with ulcerative colitis","volume":"44","author":"Onoe","year":"2017","journal-title":"J Dermatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2015.2555","article-title":"Linear IgA\/IgG bullous dermatosis reacts with multiple laminins and integrins","volume":"25","author":"Li","year":"2015","journal-title":"Eur J Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00105-018-4192-8","article-title":"Lineare IgA\/IgG-Dermatose des Kindes [Pediatric linear IgA\/IgG dermatosis","volume":"69","author":"Horv\u00e1th","year":"2018","journal-title":"Hautarzt"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5691","article-title":"Three cases of linear IgA\/IgG bullous dermatosis showing IgA and IgG reactivity with multiple antigens, particularly laminin-332","volume":"149","author":"Sakaguchi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2019.3503","article-title":"Erythrodermic linear IgA\/IgG bullous dermatosis","volume":"29","author":"Matsumoto","year":"2019","journal-title":"Eur J Dermatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.23-6-s31","article-title":"Linear IgA bullous dermatoses in an Indian child with IgG predominance: a unique case report from a tertiary care hospital of Eastern India","volume":"23","author":"Biswas","year":"2023","journal-title":"Clin Med (Lond)"},{"key":"B60","article-title":"Importance of image analysis in immunoelectron microscopy. Visualization of heterogeneous reactivity of sera from patients with linear IgA dermatitis bullosa with structures of the dermo-epidermal junction","volume":"15","author":"Haftek","year":"1995","journal-title":"Ann Pathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00231.x","article-title":"97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen","volume":"111","author":"Ishiko","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101763","article-title":"Blocking Fc\u03b1 receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies","volume":"189","author":"van der Steen","year":"2012","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1087-0024.2004.00840.x","article-title":"IgA autoimmune disorders: development of a passive transfer mouse model","volume":"9","author":"Zone","year":"2004","journal-title":"J Invest Dermatol Symp Proc"},{"key":"B64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jid.2023.05.027","article-title":"Anti-NC16A igA from patients with linear igA bullous dermatosis induce neutrophil-dependent subepidermal blistering in mice","volume":"144","author":"Jing","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02904.x","article-title":"The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis","volume":"140","author":"Caproni","year":"1999","journal-title":"Br J Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17244","article-title":"Matrix metalloproteinase-9 and neutrophil elastase from infiltrating neutrophils with neutrophil extracellular DNA traps in linear IgA bullous dermatosis: A case report","volume":"51","author":"Sugiura","year":"2024","journal-title":"J Dermatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00553","article-title":"IgA and fc\u03b1RI: pathological roles and therapeutic opportunities","volume":"10","author":"Breedveld","year":"2019","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.732977","article-title":"Anti-fc\u03b1RI monoclonal antibodies resolve igA autoantibody-mediated disease","volume":"13","author":"Bos","year":"2022","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400160","article-title":"Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo","volume":"193","author":"Recke","year":"2014","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1363032","article-title":"State-of-the-art diagnosis of autoimmune blistering diseases","volume":"15","author":"van Beek","year":"2024","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12684","article-title":"Retrospective study on autoimmune blistering disease in paediatric patients","volume":"32","author":"Kong","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"B72","first-page":"37","article-title":"Adult linear IgA bullous dermatosis: a polymorphic disorder","volume":"45","author":"Janniger","year":"1990","journal-title":"Cutis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1987.tb02292.x","article-title":"Linear IgA bullous dermatosis mimicking erythema multiforme in adult","volume":"26","author":"Lee","year":"1987","journal-title":"Int J Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00236.x","article-title":"Linear IgA dermatosis presenting with erythema annulare centrifugum lesions: report of three cases in adults","volume":"15","author":"Dippel","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.116","article-title":"Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis","volume":"48","author":"Dellavalle","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050904","article-title":"IgA-lineare Dermatose im Erwachsenenalter mit klinischen Zeichen eines Stevens-Johnson-Syndroms [Linear IgA dermatosis in an adult with clinical signs of Stevens-Johnson syndrome","volume":"50","author":"Schneck","year":"1999","journal-title":"Hautarzt"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17041","article-title":"Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review","volume":"63","author":"Wang","year":"2024","journal-title":"Int J Dermatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/s0190-9622(88)70236-4","article-title":"Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap","volume":"19","author":"Wojnarowska","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"B79","first-page":"350","article-title":"Benign chronic bullous dermatosis of childhood: a review","volume":"29","author":"Sweren","year":"1982","journal-title":"Cutis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5070\/D32TS975M4","article-title":"Linear IgA bullous dermatosis: the more frequent bullous dermatosis of children","volume":"16","author":"Kharfi","year":"2010","journal-title":"Dermatol Online J"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1177\/0394632015603796","article-title":"Bullous pemphigoid in infant post vaccination: Myth or reality","volume":"29","author":"Neri","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1991.tb00336.x","article-title":"Chronic bullous dermatosis of childhood\u2013clinical and immunological features seen in African patients","volume":"16","author":"Aboobaker","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001700","article-title":"Neonatal autoimmune subepidermal igG\/igA blistering disease with severe laryngeal and esophageal involvement: A report of a case and review of the literature","volume":"42","author":"Raiber","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/j.1468-3083.2007.02553.x","article-title":"Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosis","volume":"22","author":"Sobjanek","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb03197.x","article-title":"A clinicopathological study of mucosal involvement in linear IgA disease","volume":"119","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i13.2263","article-title":"Airway management of a patient with linear immunoglobulin A bullous dermatosis: A case report","volume":"12","author":"Nin","year":"2024","journal-title":"World J Clin cases"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1515\/jom-2022-0036","article-title":"Idiopathic linear IgA bullous dermatosis with mucosal involvement","volume":"122","author":"Ambur","year":"2022","journal-title":"J Osteopath Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJMicm2101873","article-title":"Symblepharon in linear igA bullous dermatosis","volume":"385","author":"Tsui","year":"2021","journal-title":"N Engl J Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.otorri.2019.05.006","article-title":"Linear IgA bullous dermatosis with laryngeal involvement","volume":"71","author":"Vives Ricoma","year":"2020","journal-title":"Acta Otorrinolaringol Esp (Engl Ed)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13023-018-0896-1","article-title":"Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients","volume":"13","author":"Iwata","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03163.x","article-title":"Ocular involvement in IgA-epidermolysis bullosa acquisita","volume":"141","author":"Bauer","year":"1999","journal-title":"Br J Dermatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1993.tb00049.x","article-title":"Linear IgA bullous dermatosis in a neonate","volume":"10","author":"Hruza","year":"1993","journal-title":"Pediatr Dermatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2074","article-title":"A case of neonatal linear IgA bullous dermatosis with severe eye involvement","volume":"95","author":"Romani","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15989","article-title":"Neonatal and self-healing linear immunoglobulin A dermatosis","volume":"34","author":"Giraud","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07315.x","article-title":"Linear iga disease presenting as prurigo nodularis","volume":"155","author":"Torchia","year":"2006","journal-title":"Br J Dermatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2012.1891","article-title":"Subacute prurigo-like linear iga disease","volume":"46","author":"Torchia","year":"2007","journal-title":"Int J Dermatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"13030\/qt9gv0j00w","DOI":"10.5070\/D3238036012","article-title":"Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"23","author":"Baltazard","year":"2017","journal-title":"Dermatol Online J"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16173","article-title":"A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker","volume":"48","author":"Adachi","year":"2021","journal-title":"J Dermatol"},{"key":"B99","article-title":"Chronic bullous dermatosis of childhood: relapse after puberty","volume":"88","author":"Hamann","year":"1995","journal-title":"J R Soc Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb01448.x","article-title":"Linear IgA disease of adults: association with lymphoproliferative Malignancy and possible role of other triggering factors","volume":"123","author":"Godfrey","year":"1990","journal-title":"Br J Dermatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1990.tb01707.x","article-title":"Linear IgA dermatosis and Hodgkin\u2019s lymphoma\u2013report of a case in an African and review of the literature","volume":"17","author":"Jacyk","year":"1990","journal-title":"J Dermatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06156.x","article-title":"Linear IgA disease in association with chronic lymphocytic leukaemia","volume":"151","author":"Usmani","year":"2004","journal-title":"Br J Dermatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2015.10.001","article-title":"Urticarial linear IgA bullous dermatosis (LABD) as a presenting sign of chronic lymphocytic leukemia (CLL)","volume":"1","author":"Tiger","year":"2015","journal-title":"JAAD Case Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2023.4553","article-title":"Linear IgA bullous dermatosis in association with nodal peripheral T cell lymphoma with a T follicular helper phenotype and multiple myeloma: a case report and literature review","volume":"33","author":"Masuda","year":"2023","journal-title":"Eur J Dermatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1997.tb14909.x","article-title":"Linear IgA disease in a patient with bladder carcinoma","volume":"136","author":"R\u00f3denas","year":"1997","journal-title":"Br J Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"13030\/qt7gj3j797","DOI":"10.5070\/D32311037250","article-title":"Sublamina densa-type linear IgA bullous dermatosis with IgA autoantibodies specific for type VII collagen: a case report and clinicopathological review of 32 cases","volume":"23","author":"Utsunomiya","year":"2017","journal-title":"Dermatol Online J"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13121","article-title":"Linear IgA bullous dermatosis associated with ulcerative colitis: A case report and literature review","volume":"61","author":"Kanda","year":"2020","journal-title":"Australas J Dermatol"},{"key":"B109","article-title":"Linear IGA dermatosis associated with ulcerative colitis","volume":"16","author":"Fern\u00e1ndez-Guarino","year":"2006","journal-title":"Eur J Dermatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1684\/ejd.2009.0794","article-title":"Linear IgA bullous dermatosis and ulcerative colitis treated by proctocolectomy","volume":"19","author":"Caldarola","year":"2009","journal-title":"Eur J Dermatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37210","article-title":"Successful treatment of linear igA disease and ulcerative colitis with sulfasalazine","volume":"15","author":"Fletcher","year":"2023","journal-title":"Cureus"},{"key":"B112","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jdcr.2022.12.011","article-title":"Linear IgA bullous dermatosis preceding a diagnosis of Crohn\u2019s disease","volume":"33","author":"Sadeghi","year":"2023","journal-title":"JAAD Case Rep"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2022.06.038","article-title":"Linear igA bullous dermatosis in association with crohn disease","volume":"97","author":"Weng","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1159\/000431172","article-title":"Linear igA bullous dermatosis secondary to infliximab therapy in a patient with ulcerative colitis","volume":"231","author":"Hoffmann","year":"2015","journal-title":"Dermatology"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1214011","article-title":"Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review","volume":"14","author":"Szyma\u0144ski","year":"2023","journal-title":"Front Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13827","article-title":"Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases","volume":"85","author":"Garel","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear igA bullous dermatosis: A case report and review of the literature","volume":"99","author":"Lammer","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07453.x","article-title":"Can pemphigoid be provoked by lisinopril","volume":"155","author":"Kali\u0144ska-Bienias","year":"2006","journal-title":"Br J Dermatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2007.00438.x","article-title":"Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid","volume":"24","author":"Ho","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04104.x","article-title":"Amoxicillin-clavulanic acid-induced linear immunoglobulin A bullous dermatosis: case report and review of the literature","volume":"48","author":"Panasiti","year":"2009","journal-title":"Int J Dermatol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.08.008","article-title":"Development of cyclosporine-induced linear IgA bullous dermatosis despite concurrent use of dapsone","volume":"40","author":"Libson","year":"2023","journal-title":"JAAD Case Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49185","article-title":"Drug-induced linear igA bullous dermatosis in an oncologic patient","volume":"15","author":"Quispe-G\u00e1rate","year":"2023","journal-title":"Cureus"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02081.x","article-title":"Drug-induced linear IgA disease with antibodies to collagen VII","volume":"138","author":"Wakelin","year":"1998","journal-title":"Br J Dermatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01649.x","article-title":"Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"29","author":"Waldman","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1159\/000353584","article-title":"Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature","volume":"227","author":"Kakar","year":"2013","journal-title":"Dermatology"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20164665","article-title":"Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis","volume":"91","author":"Pereira","year":"2016","journal-title":"Bras Dermatol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.12.035","article-title":"Vancomycin mediates igA autoreactivity in drug-induced linear igA bullous dermatosis","volume":"138","author":"Ishida-Yamamoto","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.03011.x","article-title":"Drug-associated linear IgA disease mimicking toxic epidermal necrolysis","volume":"34","author":"Khan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1177\/20587384211021218","article-title":"Linear IGA bullous dermatosis potentially triggered by vaccination","volume":"36","author":"Corr\u00e0","year":"2022","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2012.1851","article-title":"Linear IgA bullous dermatosis following human papillomavirus vaccination","volume":"22","author":"Ikeya","year":"2012","journal-title":"Eur J Dermatol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5070\/D37FF467XP","article-title":"Linear IgA bullous dermatosis following influenza vaccination","volume":"15","author":"Alberta-Wszolek","year":"2009","journal-title":"Dermatol Online J"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15007","article-title":"Linear IgA bullous dermatosis following Oxford AstraZeneca COVID-19 vaccine","volume":"47","author":"Hali","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14305","article-title":"Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine","volume":"50","author":"Nahm","year":"2023","journal-title":"J Cutan Pathol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2022.04.021","article-title":"Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine","volume":"24","author":"Han","year":"2022","journal-title":"JAAD Case Rep"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00158.x","article-title":"Burn-induced linear IgA dermatosis","volume":"14","author":"Gir\u00e3o","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36481","article-title":"Management options for linear immunoglobulin A (IgA) bullous dermatosis: A literature review","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13210","article-title":"Successful treatment of a case of idiopathic linear IgA bullous dermatosis with oral sulfasalazine","volume":"33","author":"Yang","year":"2020","journal-title":"Dermatol Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.9.1121","article-title":"Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil","volume":"139","author":"Farley-Li","year":"2003","journal-title":"Arch Dermatol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02315.x","article-title":"Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis","volume":"22","author":"Dauendorffer","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30309","article-title":"Linear immunoglobulin A (IgA) bullous dermatosis mimicking stevens-johnson syndrome","volume":"14","author":"Park","year":"2022","journal-title":"Cureus"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12911","article-title":"A case of recalcitrant linear IgA bullous dermatosis: Successfully treated with rituximab","volume":"32","author":"Kaya \u0130slamo\u011flu","year":"2019","journal-title":"Dermatol Ther"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.004","article-title":"Linear IgA bullous dermatosis treated with rituximab","volume":"5","author":"Pinard","year":"2019","journal-title":"JAAD Case Rep"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2023.9574","article-title":"Rituximab for linear immunoglobulin A bullous dermatosis","volume":"15","author":"Dhillon","year":"2022","journal-title":"Dermatol Rep"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1080\/09546630801958246","article-title":"Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium","volume":"19","author":"Marzano","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.1999.99015.x","article-title":"Treatment of linear IgA bullous dermatosis of childhood with colchicine","volume":"16","author":"Ang","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.049","article-title":"Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology","volume":"83","author":"van Beek","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S359589","article-title":"A probing of the issue of detecting igG, igG4 and igA antibodies to laminin 332 epitopes in mucous membrane pemphigoid: A clinical-laboratory experience of a single central european university dermatology department","volume":"15","author":"Gornowicz-Porowska","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jaad.2016.11.002","article-title":"Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases","volume":"76","author":"van Beek","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1975.tb00135.x","article-title":"Diagnostic significance of the immunofluorescent pattern in dermatitis herpetiformis","volume":"14","author":"Chorzelski","year":"1975","journal-title":"Int J Dermatol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06006.x","article-title":"U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases","volume":"151","author":"Vodegel","year":"2004","journal-title":"Br J Dermatol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12525447","article-title":"Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases","volume":"76","author":"Hintner","year":"1981","journal-title":"J Invest Dermatol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56916","article-title":"Diagnostic utility of direct immunofluorescence on paraffin-embedded skin biopsy samples for the diagnosis of autoimmune vesiculobullous lesions","volume":"16","author":"Bk","year":"2024","journal-title":"Cureus"},{"key":"B153","article-title":"New methods of diagnosing subepithelial bullous diseases","volume":"76","author":"Kowalewski","year":"1989","journal-title":"Przegl Dermatol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70094-x","article-title":"Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita","volume":"22","author":"Gammon","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/1523-1747.ep13070851","article-title":"Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits","volume":"92","author":"Prost","year":"1989","journal-title":"J Invest Dermatol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.8.1007","article-title":"A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy","volume":"139","author":"Wozniak","year":"2003","journal-title":"Arch Dermatol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2022.4312","article-title":"A case of linear IgA disease with IgA antibodies to type VII collagen demonstrated by immunofluorescence overlay antigen mapping","volume":"32","author":"Kitayama","year":"2022","journal-title":"Eur J Dermatol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07131.x","article-title":"Anti-epiligrin cicatricial pemphigoid initially limited to the upper respiratory tract","volume":"154","author":"Wozniak","year":"2006","journal-title":"Br J Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1478318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T05:10:52Z","timestamp":1736831452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1478318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":158,"alternative-id":["10.3389\/fimmu.2024.1478318"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1478318","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"article-number":"1478318"}}